Search

everythinglearnresearchcommunity

for

Search:↓

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Low-speed protocols with certified centrifuges and FDA-approved glass tubes are best for effective PRF outcomes.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness and are not FDA-approved.